当前位置:易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型:会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累,可浏览访问
(41-90)良好信誉积累,可接洽商谈
(91+ )优质信誉积累,可持续信赖
易推广会员:5年
最后认证时间:
注册号: 【已认证】
法人代表: 【已认证】
企业类型:生产商 【已认证】
注册资金:人民币万 【已认证】
产品数:86101
参观次数:3850560
已选条件
-
T19877Digitoxigenin;化合物 T19877Thevetigenin|||Echujetin|||Cerberigenin|||Digitoxigenine;Thevetigenin|||Echu
Digitoxigenin is a precursor of cardiac glycosides that acts by targeting the metastatic uveal melanoma gene signature.
价 格:¥电议型 号:T19877产 地:中国大陆
-
T19876Simiarenol;化合物 T19876UNII-6OU4M247SJ|||Simiaren-3beta-ol|||beta-Simiarenol;UNII-6OU4M247SJ|||Simiare
Simiarenol may have leishmanicidal activity against Leishmania donovani promastigotes in vitro.
价 格:¥电议型 号:T19876产 地:中国大陆
-
T1985WHI-P154;化合物WHI-P154Jak3 inhibitor ii;Jak3 inhibitor ii
WHI-P154 (Jak3 inhibitor ii) is a potent JAK3 inhibitor.
价 格:¥电议型 号:T1985产 地:中国大陆
-
T19799Ioxitalamic Acid;碘羟拉酸Telebrix|||Vasobrix|||Acidum Joxitalamicum;碘羟拉酸|||Telebrix|||Vasobrix|||Acidum
Ioxitalamic Acid (Acidum Joxitalamicum) is a medical contrast medium and enhances the contrast of structures or fluids in the body in medical imaging.
价 格:¥电议型 号:T19799产 地:中国大陆
-
T1975Infigratinib;化合物InfigratinibBGJ-398|||NVP-BGJ398;BGJ-398|||NVP-BGJ398
Infigratinib (NVP-BGJ398) (BGJ398) is an orally bioavailable pan FGFR inhibitor (IC50: 0.9/1.4/1 nM for FGFR1/2/3), >40-fold selective for FGFR versus FGFR4 and VEGFR2.
价 格:¥电议型 号:T1975产 地:中国大陆
-
T1969DBEQ;化合物DBEQJRF 12;JRF 12
DBEQ (JRF 12) is a selective, potent, reversible, and ATP-competitive p97 inhibitor.
价 格:¥电议型 号:T1969产 地:中国大陆
-
T19687Phenylethyl isothiocyanate;2-苯基乙基异硫代氰酸酯JC 5411|||JC5411|||JC-5411;JC 5411|||2-苯基乙基异硫代氰酸酯|||JC5411|||
Phenylethyl isothiocyanate (JC5411) is an HDAC inhibitor. It potentially for the treatment of benign prostatic hypertrophy.
价 格:¥电议型 号:T19687产 地:中国大陆
-
T19618(R)-(-)-JQ1 Enantiomer化合物(R)-(-)-JQ1 Enantiomer(R)-(-)2-(4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]三唑并
(R)-(-)-JQ1 Enantiomer is the stereoisomer of (+)-JQ1. (+)-JQ1 is a BET bromodomain inhibitor, acting on BRD4(1/2)(IC50 of 77 nM/33 nM in a cell-free assay)
价 格:¥电议型 号:T19618产 地:中国大陆
-
T1930JSH-23;化合物JSH-23JSH-23
JSH-23, an NF-κB inhibitor(IC50= 7.1 μM), suppresses the transcriptional activity.
价 格:¥电议型 号:T1930产 地:中国大陆
-
T19230CCR2 antagonist 4 hydrochloride化合物 T19230Teijin compound 1 hydrochloride
CCR2 antagonist 4 hydrochloride is a specific CCR2 antagonist (IC50s: 180 nM for CCR2b). It potently inhibits MCP-1-induced chemotaxis (IC50: 24 nM).
价 格:¥电议型 号:T19230产 地:中国大陆
-
T19017JAK2 JH2 Tracer;化合物 T19017JAK2 JH2 Tracer
JAK2 JH2 Tracer is a fluorescent probe for the JAK2 JH2 domain (Kd: 0.2 μM).
价 格:¥电议型 号:T19017产 地:中国大陆
-
T18873VHL Ligand-Linker Conjugates 17;化合物 T18873VHL Ligand-Linker Conjugates 17
VHL Ligand-Linker Conjugates 17 are chemical compounds that consist of a VHL ligand specialized for the E3 ubiquitin ligase, as well as a PROTAC linker. These conjugates are utilized in the synthesis of various PROTACs, including the notable ARD-266. ARD-266 is an exceptionally effective androgen receptor (AR) PROTAC degrader[1].
价 格:¥电议型 号:T18873产 地:中国大陆
-
T18872(S,R,S)-AHPC-PEG5-COOH;化合物 T18872VH032-PEG5-COOH|||E3 Ligase Ligand-Linker Conjugates 58|||VHL Ligan
(S,R,S)-AHPC-PEG5-COOH (VH032-PEG5-COOH) is a synthetic E3 ligase ligand-linker conjugate developed for use in PROTAC technology. It consists of the (S,R,S)-AHPC based VHL ligand and a 5-unit PEG linker [1].
价 格:¥电议型 号:T18872产 地:中国大陆
-
T18867Val-Cit-PAB-MMAE;化合物Val-Cit-PAB-MMAEDrug-Linker Conjugates for ADC|||inhibit|||Val-Cit-PAB-MMAE|||In
Val-Cit-PAB-MMAE is a?drug-linker conjugate for ADC. Val-Cit-PAB-MMAE contains the ADCs linker (peptide Val-Cit-PAB) and a potent tubulin inhibitor MMAE . MMAE?a potent?mitotic?inhibitor by inhibiting tubulin polymerization[1].
价 格:¥电议型 号:T18867产 地:中国大陆
-
T18826Thalidomide-O-PEG2-propargyl;化合物 T18826E3 ligase Ligand-Linker Conjugates 32;E3 ligase Ligand-Linker
Thalidomide-O-PEG2-propargyl (E3 Ligase Ligand-Linker Conjugates 32) is a chemical compound that has been synthesized as a conjugate of an E3 ligase ligand and a linker. It incorporates the cereblon ligand based on Thalidomide, along with a 2-unit PEG linker. This compound is specifically designed for use in PROTAC technology, which utilizes ligand-induced protein degradation [1].
价 格:¥电议型 号:T18826产 地:中国大陆
-
T18682SJFδ;化合物 T18682SJFδ
SJFδ is a 10-atom linker PROTAC. SJFδ degrades p38δ with a DC50 of 46.17 nM, but does not degrade p38α, p38β, or p38γ[1].
价 格:¥电议型 号:T18682产 地:中国大陆
-
T18681SJFα;化合物 T18681SJFα
SJFα is a 13-atom linker PROTAC. SJFα degrades p38α with a DC50 of 7.16 nM, but is far less effective at degrading p38δ (DC50=299 nM) and does not degrade the other p38 isoforms (β and γ) at concentrations up to 2.5 μM[1].
价 格:¥电议型 号:T18681产 地:中国大陆
-
T1868JIB-04;化合物JIB04JIB 04|||NSC 693627;JIB 04|||NSC 693627|||5-氯-2(1H)-吡啶酮 (2E)-(苯基-2-吡啶基亚甲基)腙
JIB-04 (NSC 693627) is a pan-selective Jumonji histone demethylase inhibitor.
价 格:¥电议型 号:T1868产 地:中国大陆
-
T18602VH032-thiol-C6-NH2;化合物 T18602VHL Ligand-Linker Conjugates 14|||E3 ligase Ligand-Linker Conjugates 29
VH032-thiol-C6-NH2, also known as VHL Ligand-Linker Conjugates 14, is a synthesized compound that functions as an E3 ligase ligand-linker conjugate. This compound combines the VH032 based VHL ligand with a linker commonly utilized in PROTAC technology.
价 格:¥电议型 号:T18602产 地:中国大陆
-
T18555Pomalidomide-PEG2-Tos;化合物 T18555Cereblon Ligand-Linker Conjugates 16|||E3 ligase Ligand-Linker Conju
Pomalidomide-PEG2-Tos is a compound that consists of an E3 ligase ligand-linker conjugate. It is composed of a cereblon ligand conjugated to a two-unit PEG linker[1].
价 格:¥电议型 号:T18555产 地:中国大陆